Ann Merchant
Director/Board Member chez ALVOTECH
Fortune : 129 312 $ au 31/03/2024
Profil
Ann Merchant is currently a Non-Executive Director at Biodexa Pharmaceuticals Plc and a Director at Alvotech hf.
She is also an Independent Non-Executive Director at Alvotech since 2022.
Previously, she held the position of Vice President & Head-Global Supply Chain at MorphoSys AG starting in 2018.
Prior to that, Ms. Merchant worked at Amgen, Inc. as the Head-International Supply Chain & Site Head from 1994 to 2011.
She then served as the President of Schreiner Medipharm from 2011 to 2018.
Ms. Merchant holds an MBA from Henley Business School Ltd.
and an undergraduate degree from Georgetown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALVOTECH
0,00% | 15/02/2024 | 10 582 ( 0,00% ) | 129 312 $ | 31/03/2024 |
Postes actifs de Ann Merchant
| Sociétés | Poste | Début |
|---|---|---|
| ALVOTECH | Director/Board Member | 16/06/2022 |
| MORPHOSYS AG | Corporate Officer/Principal | 01/01/2018 |
| BIODEXA PHARMACEUTICALS PLC | Director/Board Member | 31/12/2023 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Director/Board Member | - |
Anciens postes connus de Ann Merchant
| Sociétés | Poste | Fin |
|---|---|---|
| Schreiner Medipharm | President | 01/08/2018 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 |
Formation de Ann Merchant
| Henley Business School Ltd. | Masters Business Admin |
| Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| MORPHOSYS AG | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| ALVOTECH | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |
| Schreiner Medipharm |
